DuPont de Nemours
+ Follow
DuPont de Nemours Competitors & Alternatives
DuPont de Nemours competitors and alternatives
Jump
- Stock Price
- Market Cap
- Employees
-
Income Statement
- Revenue
- Revenue by Product / Services
- Revenue by Geography
- Research and Development
- Operating Income
- Tax Rate (%)
- Net Income
-
Assets & Liabilities | Cash Flow
- Total Assets
- Total Liabilities
- Capital Expenditures (Capex)
-
Profitability
- Operating Income Margin (%)
- Net Income Margin (%)
- EBITDA
- Free Cash Flow (FCF)
-
Ratios
- Return on Equity (ROE)
- Return on Assets (ROA)
- Debt to Equity
-
Valuation
- Enterprise value
- Enterprise value to Revenue
- Enterprise value to EBITDA
Company
Ticker
DD
Headquarter
Wilmington
,DE
US
CEO
Mr. Edward D. Breen
Industry
Chemicals - Specialty
Stock Price
Stock Price
Market Cap
$34.94B
Employees
Years
- 2021
- 2022
- 2023
Employees
- 28.00K
- 23.00K
- 24.00K
Y/Y
17.65%
17.86%
4.35%
Income Statement
Revenue
Years
- 2021
- 2022
- 2023
Revenue
- $12.57B
- $13.02B
- $12.07B
Y/Y
38.39%
3.59%
7.29%
Revenue by Products / Services
Revenue by Geography
Research and Development
Years
- 2021
- 2022
- 2023
Research and Development
- $557.00M
- $536.00M
- $508.00M
Y/Y
35.23%
3.77%
5.22%
Operating Income
Years
- 2021
- 2022
- 2023
Operating Income
- $2.10B
- $2.29B
- $2.31B
Y/Y
16.9%
8.95%
0.87%
Tax Rate (%)
Years
- 2021
- 2022
- 2023
Tax Rate (%)
- 16.00%
- 27.00%
- -6.00%
Y/Y
1977.22%
62.89%
121.51%
Net Income
Years
- 2021
- 2022
- 2023
Net Income
- $1.18B
- $1.06B
- $423.00M
Y/Y
140.95%
9.86%
60.13%
Assets & Liabilities | Cash Flow
Total Assets
Years
- 2021
- 2022
- 2023
Total Assets
- $45.71B
- $41.40B
- $38.55B
Y/Y
35.54%
9.42%
6.88%
Total Liabilities
Years
- 2021
- 2022
- 2023
Total Liabilities
- $18.66B
- $14.45B
- $13.83B
Y/Y
41.39%
22.53%
4.33%
Capital Expenditures (Capex)
Years
- 2021
- 2022
- 2023
Capital Expenditures (Capex)
- -$3.24B
- -$743.00M
- -$619.00M
Y/Y
156.09%
77.05%
16.69%
Profitability
Operating Income Margin (%)
Years
- 2021
- 2022
- 2023
Operating Income Margin (%)
- 16.71%
- 17.58%
- 19.12%
Y/Y
34.87%
5.21%
8.76%
Net Income Margin (%)
Years
- 2021
- 2022
- 2023
Net Income Margin (%)
- 9.37%
- 8.15%
- 3.51%
Y/Y
166.5%
13.02%
56.93%
EBITDA
2020 | -201000000.00 |
---|---|
2021 | 3012000000.00 |
2022 | 3185000000.00 |
2023 | 2047000000.00 |
Years
- 2021
- 2022
- 2023
EBITDA
- $3.01B
- $3.19B
- $2.05B
Y/Y
1598.51%
5.74%
35.73%
Free Cash Flow (FCF)
2020 | 2831000000.00 |
---|---|
2021 | -956000000.00 |
2022 | -155000000.00 |
2023 | 1572000000.00 |
Years
- 2021
- 2022
- 2023
Free Cash Flow (FCF)
- -$956.00M
- -$155.00M
- $1.57B
Y/Y
133.77%
83.79%
1114.19%
Ratios
Return on Equity (ROE)
Years
- 2021
- 2022
- 2023
Return on Equity (ROE)
- 4.45%
- 4.00%
- 1.74%
Y/Y
159.65%
10.11%
56.5%
Return on Assets (ROA)
Years
- 2021
- 2022
- 2023
Return on Assets (ROA)
- 2.58%
- 2.56%
- 1.10%
Y/Y
163.7%
0.78%
57.03%
Debt to Equity
Years
- 2021
- 2022
- 2023
Debt to Equity
- 40.79%
- 30.47%
- 32.09%
Y/Y
0.59%
25.3%
5.32%
Valuation
Enterprise Value
Years
- 2021
- 2022
- 2023
Enterprise value
- $52.61B
- $38.62B
- $40.09B
Y/Y
26.49%
26.58%
3.81%
Enterprise value to Revenue
Years
- 2021
- 2022
- 2023
Enterprise value to Revenue
- 4.19
- 2.97
- 3.32
Y/Y
19.32%
29.13%
11.97%
Enterprise value to EBITDA
Years
- 2021
- 2022
- 2023
Enterprise value to EBITDA
- 17.47
- 12.13
- 19.59
Y/Y
104.91%
30.57%
61.52%